Below you will find information about research projects we have previously funded. Learn more about our current projects or visit the EB Research Network for more information on EB research.
Projects funded by Cure EB (previously Sohana Research Fund):
Prof Jemima Mellerio, London, UK Read more
Prof Deborah Falla, Solihull UK Read more
Prof Liam Grover, Birmingham UK Read more
Dr Andrew South, London UK Read more
Prof Dr Sabine Eming, Cologne, Germany Read more
Prof John McGrath, London, UK Read more
Dr Peter van den Akker, Dundee, UK Read more
Can gene-modified skin cells provide a useful treatment for RDEB? *Project funded by Cure EB (London, UK) Read more
TGF-β signalling in RDEB Squamous Cell Carcinoma (Dundee, UK) Read more
Investigating the use of Ultrasound as a Delivery Mechanism for an epidermolysis bullosa simplex Therapy (Dundee, UK) Read more
Development of a Skin Fragility Assessment Tool (Dundee, UK) Read more
EBS Genotyping Database (Dundee, UK) Read more
Defining the role of kindlin-1 in the regulation of microtubule stability and mitosis (Edinburgh, UK) Read more
Cell therapy research sees quality of life improvement in a clinical trial for adults (ADSTEM) with recessive dystrophic epidermolysis bullosa *Project funded by Cure EB (London, UK) Read more
Longitudinal retrospective study on bone health in adults with RDEB (London, UK) Read more
To identify modifier genes in junctional EB that affect the severity of symptoms experienced by different patients with the same primary gene defect (Maine, USA) Read more
Limbal stem-cell therapy for RDEB *Project funded by Cure EB (Minnesota, USA) Read more
To validate findings that will develop a drug to counteract scarring and Squamous Cell Carcinoma in patients with recessive dystrophic EB (Nice, France) Read more
To develop therapies which combine ex vivo gene therapy with stem cell transplantation for Junctional EB. (EB House, Austria) Read more
Novel approaches for read-through of nonsense mutations in COL7A1 (Philadelphia, USA) Read more
Dissecting the role of basement membrane components in a xenograft model of cutaneous SCC (QMUL, UK) Read more
A prospective phase I/II study to evaluate allogeneic mesenchymal stromal cells for the treatment of children with Recessive Dystrophic epidermolysis bullosa (EBSTEM) *Project funded by Cure EB (London, UK) Read more
A TALEN-based approach to developing safer, more effective treatments for people with EB *Project funded by Cure EB (Minnesota, USA) Read more
To be in a position to move to clinical trials of siRNA on EB simplex (Dundee, UK) Read more